New hope for tough cancers: experimental drug targets treatment resistance
Disease control
Ongoing
This study is testing a new drug called 9-ING-41, which is designed to block a protein that helps cancer cells survive and resist chemotherapy. It is for adults with advanced or metastatic cancers, including pancreatic, breast, and lung cancers, that have worsened despite standar…
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Apr 17, 2026 16:10 UTC